Tandem Sells Shares.
Tandem Investment Advisors Trims Positions in O'Reilly, Medpace, Genpact, and Others in Q1.
Anonymous
Key Points
1
Brad W. Beckham sold 13,635 O'Reilly Automotive shares on May 8 at an average price of $95, trimming Tandem's ORLY stake and leaving him with 12,250 shares worth about $1.16 million after the sale.
2
Medpace General Counsel Stephen P. Ewald sold 16,349 Medpace shares on May 28 at $450 per share, for a total of $7,357,050.
3
Genpact position declined 10.3% in Q1 to 2,531,821 shares (roughly $94.31 million), making Genpact Tandem's 4th-largest holding at 4.6% of the portfolio; the fund also sold 290,112 Genpact shares in the quarter.
4
Expeditors International of Washington (EXPD) stake was cut 9.0% to 298,670 shares (about $42.779 million), about 2.1% of Tandem's portfolio and 25th-largest holding; the quarter included selling 29,586 EXPD shares.
Tandem Investment Advisors trimmed its stakes in several major companies during the first quarter of 2025, cutting positions in stocks ranging from O'Reilly Automotive to Genpact, according to Ticker Report and Watchlist News. The moves signal a broad pullback across the firm's portfolio, with reductions ranging from 2.6% to 15.8% depending on the stock.
The largest dollar-value cut came in Genpact, where Tandem sold 290,112 shares, bringing its stake down 10.3% to 2,531,821 shares worth roughly $94.31 million. Despite the trim, Genpact remains the firm's fourth-largest holding at 4.6% of its total portfolio.
Tandem Cuts ORLY and MEDP by Nearly 16% Each
Tandem's sharpest percentage cuts hit O'Reilly Automotive and Medpace Holdings equally. The firm slashed its ORLY position by 15.8% to 43,491 shares, now valued at about $4.02 million, according to Watchlist News. It made the exact same 15.8% cut to Medpace, trimming 2,244 shares to land at 11,929 shares worth roughly $5.73 million.
The ORLY cuts came alongside notable insider activity at the company. CEO Brad W. Beckham sold 13,635 O'Reilly shares on May 8 at an average price of $95 per share. After the sale, Beckham held 12,250 shares worth about $1.16 million. At Medpace, General Counsel Stephen P. Ewald sold 16,349 shares on May 28 at $450 each, a transaction totaling $7,357,050.
Expeditors and Becton Dickinson Face Smaller Trims
Tandem cut its Expeditors International stake by 9.0%, selling 29,586 shares to bring its total to 298,670 shares. That position is now valued at about $42.78 million, making it roughly 2.1% of the firm's portfolio and its 25th-largest holding, according to Watchlist News.
Becton, Dickinson and Company saw the smallest reduction, just 2.6%, according to Ticker Report. Tandem now holds 240,501 BDX shares worth around $37.81 million. While the cut is modest in percentage terms, it continues the firm's overall pattern of trimming across nearly every major position in the quarter.
Amphenol and Waste Connections Also Shed From Portfolio
Beyond the headline cuts, Tandem also reduced its position in Amphenol Corporation by 28.4% in the first quarter, according to both Ticker Report and Watchlist News. The firm sold 271,000 shares, bringing its Amphenol stake down to 678,771 shares. That is the steepest percentage cut the firm made across all disclosed positions.
Waste Connections also took a hit, with Tandem cutting that position by 10.7% to 324,023 shares, according to Watchlist News. Together, the wave of cuts across Amphenol, Waste Connections, Genpact, ORLY, Medpace, Expeditors, and Becton Dickinson paints a clear picture: Tandem spent Q1 2025 actively reducing exposure across a wide range of sectors.
Sentiment
Mostly PositiveNEGATIVENEUTRALPOSITIVE
Publishers
15
Articles
11
Reach
26
A
AnonymousAuthor